Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FBXW7 |
Variant | R465Y |
Impact List | missense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | FBXW7 R465Y lies within the WD repeat domain of the Fbxw7 protein (UniProt.org). R465Y has not been characterized however, other R465 hotspots inactivate Fbxw7, and therefore, R465Y is predicted to lead to a loss of function (PMID: 17646409, PMID: 17909001, PMID: 19340001). |
Associated Drug Resistance | |
Category Variants Paths |
FBXW7 mutant FBXW7 inact mut FBXW7 R465Y |
Transcript | NM_033632.3 |
gDNA | chr4:g.152328232_152328233delCGinsTA |
cDNA | c.1393_1394delCGinsTA |
Protein | p.R465Y |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_047415901.1 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
XM_047415898.1 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
XM_011532085.3 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
XM_024454122.1 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
NM_033632 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
XM_047415900.1 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
NM_001349798.2 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
XM_047415897.1 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
XM_047415899.1 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
NM_001349798.1 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
XM_024454123.1 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
XM_024454124.1 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
NM_033632.3 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
XM_011532084.3 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
XM_024454121.1 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
XM_017008362 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
XM_011532085.2 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
NM_033632.3 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
XM_011532084 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
XM_011532083 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
XM_024454123.2 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
XM_011532085 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
XM_011532084.2 | chr4:g.152328232_152328233delCGinsTA | c.1393_1394delCGinsTA | p.R465Y | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|